Annual Statements Open main menu

Scott's Liquid Gold - Inc. - Quarter Report: 2023 June (Form 10-Q)

10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-13458

SCOTT’S LIQUID GOLD-INC.

(Exact name of registrant as specified in its charter)

Colorado

84-0920811

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

8400 E. Crescent Parkway, Suite 450, Greenwood Village, CO

80111

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (303) 373-4860

Securities registered pursuant to Section 12(b) of the Exchange Act.

 

Title of each class

 

Trading Symbol

 

Name of exchange on which registered

None

 

None

 

None

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of August 11, 2023, the registrant had 12,997,423 shares of its common stock, $0.10 par value per share, outstanding.

 


 

CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, in addition to historical information. All statements, other than statements of historical facts, included in this Report that address activities, events, or developments with respect to our financial condition, results of operations, or economic performance that we expect, believe, or anticipate will or may occur in the future, or that address plans and objectives of management for future operations, are forward-looking statements. You can typically identify forward-looking statements by the use of words, such as “may,” “could,” “should,” “assume,” “project,” “believe,” “anticipate,” “expect,” “estimate,” “potential,” “plan,” and other similar words. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The forward-looking statements contained in this Report are based on management’s current expectations and are subject to uncertainty and changes in circumstances. We cannot assure you that future developments affecting us will be those that we have anticipated. Forward-looking statements and our performance inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to:

the impact of the COVID-19 pandemic on our business, suppliers, consumers, customers, and employees;
disruptions or inefficiencies in the supply chain;
dependence on third-party vendors and on sales to major customers;
a continued shift in the retail market from food and drug stores to mass merchandisers, club stores, dollar stores, e-commerce retailers, and subscription services;
competition from large consumer products companies in the United States;
competitive factors, including any decrease in distribution of (i.e., retail stores carrying) our significant products;
new competitive products and/or technological changes;
the need for effective advertising of our products and limited resources available for such advertising;
unfavorable economic conditions;
changing consumer preferences and the continued acceptance of each of our significant products in the marketplace;
the degree of success of any new product or product line introduction by us;
the degree of success of the integration of product lines or businesses we may acquire;
changes in the regulation of our products, including applicable environmental, U.S. and international Food and Drug Administration regulations and process-audit compliance;
the loss of any executive officer or other personnel;
future losses which could affect our liquidity;
the risk that we may not be able to remediate the existing material weakness related to our finance department lacking a sufficient number of trained professionals with technical accounting expertise to process and account for complex, non-routine transactions in accordance with GAAP and develop and maintain effective internal controls over financial reporting;
other matters discussed in this Report, including the risks described in the Risk Factors section of this Report and in our Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent Quarterly Reports on Form 10-Q.

We caution you that forward-looking statements are not guarantees of future performance and that actual results or performance may be materially different from those expressed or implied in the forward-looking statements. The forward-looking statements in this Report speak as of the filing date of this Report. Although we may from time to time voluntarily update our prior forward-looking statements, we undertake no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this Report.

 

 

 


 

TABLE OF CONTENTS

Page

PART I

 

Item 1.

Financial Statements

1

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

Item 4.

Controls and Procedures

22

PART II

 

Item 1A.

Risk Factors

23

Item 6.

Exhibits

23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

PART I

 

ITEM 1. FINANCIAL STATEMENTS.

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except per share data)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 30,

 

 

June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net sales

$

1,538

 

 

$

1,120

 

 

$

3,268

 

 

$

2,928

 

Cost of sales

 

824

 

 

 

737

 

 

 

1,826

 

 

 

1,599

 

Gross profit

 

714

 

 

 

383

 

 

 

1,442

 

 

 

1,329

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

120

 

 

 

174

 

 

 

275

 

 

 

326

 

Selling

 

574

 

 

 

867

 

 

 

1,146

 

 

 

1,970

 

General and administrative

 

638

 

 

 

776

 

 

 

1,255

 

 

 

1,561

 

Intangible asset amortization

 

51

 

 

 

103

 

 

 

101

 

 

 

226

 

Impairment of goodwill and intangible assets

 

-

 

 

 

3,589

 

 

 

-

 

 

 

3,589

 

Total operating expenses

 

1,383

 

 

 

5,509

 

 

 

2,777

 

 

 

7,672

 

Loss from operations

 

(669

)

 

 

(5,126

)

 

 

(1,335

)

 

 

(6,343

)

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(6

)

 

 

(18

)

 

 

(113

)

 

 

(57

)

Loss before income taxes and discontinued operations

 

(675

)

 

 

(5,144

)

 

 

(1,448

)

 

 

(6,400

)

Income tax expense

 

(6

)

 

 

(52

)

 

 

(2

)

 

 

(52

)

Loss from continuing operations

 

(681

)

 

 

(5,196

)

 

 

(1,450

)

 

 

(6,452

)

Income from discontinued operations, net of taxes

 

228

 

 

 

863

 

 

 

1,366

 

 

 

1,668

 

Net loss

$

(453

)

 

$

(4,333

)

 

$

(84

)

 

$

(4,784

)

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net income (loss) per common shares:

 

 

 

 

 

 

 

 

 

 

 

Loss from continuing operations

$

(0.05

)

 

$

(0.41

)

 

$

(0.11

)

 

$

(0.51

)

Income from discontinued operations

$

0.02

 

 

$

0.07

 

 

$

0.11

 

 

$

0.13

 

Net loss

$

(0.03

)

 

$

(0.34

)

 

$

-

 

 

$

(0.38

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

12,908

 

 

 

12,749

 

 

 

12,853

 

 

 

12,745

 

 




 

 

 



 

 

 

 

 

 

 

 

1


 

See accompanying notes to these Condensed Consolidated Financial Statements.

2


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except par value amounts)

 

 

June 30,

 

 

December 31,

 

 

2023

 

 

2022

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash

$

608

 

 

$

49

 

Accounts receivable, net

 

1,182

 

 

 

1,833

 

Inventories

 

523

 

 

 

1,097

 

Income taxes receivable

 

-

 

 

 

239

 

Prepaid expenses

 

304

 

 

 

243

 

Assets held for sale

 

2,280

 

 

 

2,591

 

Assets of discontinued operations

 

-

 

 

 

1,235

 

Total current assets

 

4,897

 

 

 

7,287

 

 

 

 

 

 

 

Intangible assets, net

 

805

 

 

 

906

 

Operating lease right-of-use assets

 

2,364

 

 

 

2,491

 

Other assets

 

45

 

 

 

47

 

Total assets

$

8,111

 

 

$

10,731

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

1,325

 

 

$

1,407

 

Accrued expenses

 

107

 

 

 

311

 

Current portion of long-term debt, net of debt issuance costs

 

1,210

 

 

 

3,384

 

Operating lease liabilities, current portion

 

280

 

 

 

270

 

Total current liabilities

 

2,922

 

 

 

5,372

 

 

 

 

 

 

 

Operating lease liabilities, net of current

 

2,369

 

 

 

2,512

 

Other liabilities

 

27

 

 

 

27

 

Total liabilities

 

5,318

 

 

 

7,911

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred Stock, no par value, authorized 20,000 shares; no shares issued and outstanding

 

-

 

 

 

-

 

Common Stock; $0.10 par value, authorized 50,000 shares; issued and outstanding 12,997 shares (2023) and 12,797 shares (2022)

 

1,300

 

 

 

1,280

 

Capital in excess of par

 

7,949

 

 

 

7,912

 

Accumulated deficit

 

(6,456

)

 

 

(6,372

)

Total shareholders’ equity

 

2,793

 

 

 

2,820

 

Total liabilities and shareholders’ equity

$

8,111

 

 

$

10,731

 

 

 




 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

3


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

 

Condensed Consolidated Statements of Shareholders’ Equity (Unaudited)

(in thousands)

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital in Excess of Par

 

 

(Accumulated Deficit) Retained Earnings

 

 

Total

 

Balance, December 31, 2022

 

12,797

 

 

$

1,280

 

 

$

7,912

 

 

$

(6,372

)

 

$

2,820

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

7

 

 

 

-

 

 

 

7

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

369

 

 

 

369

 

Balance, March 31, 2023 (Unaudited)

 

12,797

 

 

 

1,280

 

 

 

7,919

 

 

 

(6,003

)

 

 

3,196

 

Stock-based compensation

 

200

 

 

 

20

 

 

 

30

 

 

 

-

 

 

 

50

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(453

)

 

 

(453

)

Balance, June 30, 2023 (Unaudited)

 

12,997

 

 

$

1,300

 

 

$

7,949

 

 

$

(6,456

)

 

$

2,793

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2021

 

12,727

 

 

$

1,273

 

 

$

7,789

 

 

$

2,479

 

 

$

11,541

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

35

 

 

 

-

 

 

 

35

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(451

)

 

 

(451

)

Restricted stock unit vesting

 

22

 

 

 

2

 

 

 

26

 

 

 

-

 

 

 

28

 

Balance, March 31, 2022 (Unaudited)

 

12,749

 

 

 

1,275

 

 

 

7,850

 

 

 

2,028

 

 

 

11,153

 

Stock-based compensation

 

-

 

 

 

-

 

 

 

22

 

 

 

-

 

 

 

22

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,333

)

 

 

(4,333

)

Balance, June 30, 2022 (Unaudited)

 

12,749

 

 

$

1,275

 

 

$

7,872

 

 

$

(2,305

)

 

$

6,842

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

4


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

 

 

Six Months Ended

 

 

June 30,

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

Net loss

$

(84

)

 

$

(4,784

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

224

 

 

 

339

 

Gain on disposal of discontinued operations

 

(787

)

 

 

-

 

Stock-based compensation

 

57

 

 

 

85

 

Impairment of goodwill and intangible assets

 

-

 

 

 

3,589

 

Change in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

651

 

 

 

1,823

 

Inventories

 

958

 

 

 

(165

)

Prepaid expenses and other assets

 

(59

)

 

 

143

 

Income taxes receivable

 

239

 

 

 

45

 

Accounts payable, accrued expenses, and other liabilities

 

(292

)

 

 

(609

)

Total adjustments to net loss

 

991

 

 

 

5,250

 

Net cash provided by operating activities

 

907

 

 

 

466

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Proceeds from sale of discontinued operations

 

1,936

 

 

 

-

 

Purchase of software

 

-

 

 

 

(142

)

Net cash provided by (used in) investing activities

 

1,936

 

 

 

(142

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

Proceeds from term loans

 

250

 

 

 

-

 

Repayments of term loans

 

(30

)

 

 

(2,000

)

Proceeds from revolving credit facility

 

2,795

 

 

 

14,737

 

Repayments of revolving credit facility

 

(5,299

)

 

 

(14,015

)

Net cash used in financing activities

 

(2,284

)

 

 

(1,278

)

 

 

 

 

 

 

Net increase (decrease) in cash and restricted cash

 

559

 

 

 

(954

)

 

 

 

 

 

 

Cash, beginning of period

 

49

 

 

 

1,270

 

Cash, end of period

$

608

 

 

$

316

 

 

 

 

 

 

 

Supplemental disclosures:

 

 

 

Cash paid during the period for interest

$

109

 

 

$

170

 



 

 

 

 

 

 

 

 

 

 

See accompanying notes to these Condensed Consolidated Financial Statements.

5


 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands, except per share data)

Note 1. Organization and Summary of Significant Accounting Policies

(a) Company Background

Scott’s Liquid Gold-Inc., a Colorado corporation was incorporated on February 15, 1954. Scott’s Liquid Gold-Inc. and its wholly-owned subsidiaries (collectively, the “Company,” “we,” “our,” or “us”) develop, market and sell high quality products. Our business is comprised of two segments: household products and health and beauty care products.

(b) Principles of Consolidation

Our Condensed Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Closed in July 2023 and effective June 30, 2023, we entered into a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Alpha® Skin Care brand (the "Alpha Purchase Agreement"). The transactions contemplated by the Alpha Purchase Agreement are subject to customary conditions and closing deliveries by both Neoteric and the Alpha Buyer. The assets of Alpha® are classified as assets held for sale as of June 30, 2023 and December 31, 2022, and their operations have been classified as income from discontinued operations for all periods presented. The Alpha product line was previously classified under our health and beauty care products segment. See Note 3 for further information.

Closed in July 2023 and effective June 30, 2023, we entered into a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the BIZ® brand. The assets of BIZ® are classified as assets held for sale as of June 30, 2023 and December 31, 2022, and their operations have been classified as income from discontinued operations for all periods presented. The BIZ® product line was previously classified under our household products segment. See Note 3 for further information.

On January 23, 2023, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Scott's Liquid Gold® brand, including the Wood Care and Floor Restore products. We have reflected the operations of the Scott's Liquid Gold® brand as discontinued operations for all periods presented, which was previously classified under our household products segment. See Note 3 for further information.

On December 15, 2022, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Prell® product line. We have reflected the operations of the Prell® product line as discontinued operations for all periods presented, which was previously classified under our health and beauty care products segment. See Note 3 for further information.

(c) Basis of Presentation

The unaudited Condensed Consolidated Statements of Operations, Condensed Consolidated Balance Sheets, and Condensed Consolidated Statements of Cash Flows included in this Report have been prepared by the Company. In our opinion, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position at June 30, 2023 and results of operations and cash flows for all periods have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These Condensed Consolidated Financial Statements should be read in conjunction with our financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the period ended June 30, 2023 are not necessarily indicative of the operating results for the full year and are unaudited. Certain prior year amounts have been reclassified to conform to the current period presentation.

6


 

(d) Use of Estimates

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts in our financial statements of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include, but are not limited to, the realization of deferred tax assets, reserves for slow moving and obsolete inventory, customer returns and allowances, intangible asset useful lives and amortization method, operating lease right-of-use assets and operating lease liabilities, and stock-based compensation. Actual results could differ from our estimates.

(e) Inventories Valuation and Reserves

Inventories consist of raw materials and finished goods and are stated at the lower of cost (first-in, first-out method) or net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We estimate an inventory reserve, which is generally not material to our financial statements, for slow moving and obsolete products and raw materials based upon, among other things, an assessment of historical and anticipated sales of our products. In the event that actual results differ from our estimates, the results of future periods may be impacted.

Our remaining raw materials balance is to be sold to contract manufacturing partners based on production demand.

(f) Assets Held for Sale and Discontinued Operations

Assets classified as held for sale are measured at the lower of their carrying amount or fair value less costs to sell and are not depreciated or amortized. Fair value is determined based on the total consideration expected to be received by the Company. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Disposal groups that meet the discontinued operations criteria by the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 205-20-45 are classified as discontinued operations and are excluded from continuing operations and segment results for all periods presented.

(g) Leases

Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.

Certain nonlease components, such as maintenance and other services provided by the lessor, are included in the valuation of the lease. Leases with an initial term of 12 months or less, which are not material to our financial statements, are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term. Lease agreements with lease and nonlease components are combined as a single lease component.

(h) Intangible Assets

Intangible assets with finite lives, such as trade names, and formulas, are amortized over their estimated useful lives, generally ranging from 10 to 15 years. Amortization expense related to intangible assets is included in Operating Expenses on the Condensed Consolidated Statement of Operations.

Internal-use software costs recognized as an intangible asset relates to capitalizable costs of computer software obtained for internal-use as defined by ASC 350-40-30-1. All other internal-use software costs are expensed as incurred by the Company. Amortization will be recorded over the estimated useful life of the software once the software is ready for its intended use and placed into service. In the second quarter of 2022, our internal-use software was implemented for its intended use. The estimated useful life for internal-use software is five years and will be periodically reassessed based on considerations for obsolescence, technology, competition, and other economic factors.

7


 

(i) Financial Instruments

Financial instruments which potentially subject us to concentrations of credit risk include cash and accounts receivable. We maintain our cash balances in the form of bank demand deposits with financial institutions that we believe are creditworthy. Historically, we have maintained balances in various operating accounts in excess of federally insured limits. We establish an allowance for doubtful accounts, which is generally not material to our financial statements, based upon factors surrounding the credit risk of specific customers, historical trends and other information. We have no significant financial instruments with off-balance sheet risk of accounting loss, such as foreign exchange contracts, option contracts or other foreign currency hedging arrangements.

The recorded amounts for cash, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these financial instruments.

(j) Income Taxes

Income taxes reflect the tax effects of transactions reported in the Condensed Consolidated Financial Statements and consist of taxes currently payable plus deferred income taxes related to certain income and expenses recognized in different periods for financial and income tax reporting purposes. Deferred income tax assets and liabilities are recognized for the future income tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases. A valuation allowance is established when it is more-likely-than-not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which related temporary differences become deductible. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

Taxes are reported based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits or expense. We classify penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the Condensed Consolidated Statements of Operations or accrued on the Condensed Consolidated Balance Sheets.

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items which are recorded in the interim period. The provision for income taxes for the three and six months ended June 30, 2023 differs from the amount that would be provided by applying the statutory U.S. federal income tax rate of 21% to pre-tax income primarily due to valuation allowance. The effective tax rate for the six months ended June 30, 2023 and 2022 was 0.1% and 0.0% respectively.

The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, and permanent differences. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known or as the tax environment changes.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to realize deferred tax assets. Based upon the historical and anticipated future losses, management has determined that the deferred tax assets do not meet the more likely than not threshold for realizability. Accordingly, a valuation allowance has been recorded against the Company’s net deferred tax assets as of June 30, 2023, and December 31, 2022.

(k) Revenue Recognition

Our revenue recognition policy is significant because the amount and timing of revenue is a key component of our results of operations. Certain criteria are required to be met in order to recognize revenue. If these criteria are not met, then the associated revenue is deferred until it is met. When consideration is received in advance of the delivery of goods or services, a contract liability is recorded. Our revenue contracts are identified when purchase orders are received and accepted from customers and represent a single performance obligation to sell our products to a customer.

Net sales reflect the transaction prices for contracts, which include products shipped at selling list prices reduced by variable consideration. Variable consideration includes estimates for expected customer allowances, promotional programs for consumers, and sales returns. Based on our customer-by-customer history, our variable consideration estimates are generally accurate and subsequent adjustments are generally immaterial.

8


 

Variable consideration is primarily comprised of customer allowances. Customer allowances primarily include reserves for trade promotions to support price features, displays, slotting fees, and other merchandising of our products to our customers. Promotional programs for consumers primarily include coupons, rebates, and certain other promotional programs, and do not represent a significant portion of variable consideration. The costs of both customer allowances and promotional programs for consumers are estimated using either the expected value or most likely amount approach, depending on the nature of the allowance, using all reasonably available information, including our historical experience and current expectations. Customer allowances and promotional programs for consumers are reflected in the transaction price when sales are recorded. We may adjust our estimates based on actual results and consideration of other factors that cause allowances. In the event that actual results differ from our estimates, the results of future periods may be impacted.

Sales returns are generally not material to our financial statements, and do not comprise a significant portion of variable consideration. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce our revenue in that period.

Sales are recorded at the time that control of the products is transferred to customers. In evaluating the timing of the transfer of control of products to customers, we consider several indicators, including significant risks and rewards of products, our right to payment, and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to customers.

We have also established an allowance for doubtful accounts. We estimate this allowance based upon, among other things, an assessment of the credit risk of specific customers and historical trends. We believe our allowance for doubtful accounts is adequate to absorb any losses which may arise. In the event that actual losses differ from our estimates, the results of future periods may be impacted.

Customer allowances for trade promotions and allowance for doubtful accounts are included in net accounts receivable on the Condensed Consolidated Balance Sheets and were as follows:

 

June 30, 2023

 

 

December 31, 2022

 

Trade promotions

$

141

 

 

$

361

 

Allowance for doubtful accounts

 

36

 

 

 

59

 

 

$

177

 

 

$

420

 

(l) Advertising Costs

We expense advertising costs as incurred.

(m) Stock-Based Compensation

We account for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of stock options with only service conditions using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the vesting period using the straight-line method, which approximates the service period.

The Company issues restricted stock unit ("RSUs") awards with restrictions that lapse upon the passage of time (service vesting) and satisfaction of market conditions targeted to our Company’s stock price. For those RSU awards with only service vesting, the Company recognizes compensation cost on a straight-line basis over the service period. For awards with both market and service conditions, the Company starts recognizing compensation cost over the requisite service period, with the effect of the market conditions reflected in the calculation of the award's fair value at grant date. The Company values awards with only service vesting requirements based on the grant date share price. The Company values awards with market and service conditions using a Monte Carlo simulation. The Company determines the requisite service period for awards with both market and service conditions based on the longer of the explicit service period and the derived service period. Stock awards that contain market vesting conditions are included in the computations of diluted EPS reflecting the average number of shares that would be issued based on the highest 30-day average market price during the reporting periods, if their effect is dilutive. If the condition is based on an average of market prices over some period of time, the corresponding average for the period is used.

9


 

(n) Operating Costs and Expenses Classification

Cost of sales includes costs associated with manufacturing and distribution including labor, materials, freight-in, purchasing and receiving, quality control, repairs, maintenance, and other indirect costs, as well as warehousing and distribution costs. We classify freight-out as selling expenses. Other selling expenses consist primarily of costs for sales and sales support personnel, brokerage commissions, and promotional costs. Freight-out costs included in selling expenses totaled $112 and $158 for the three months ended June 30, 2023 and 2022, respectively, and totaled $199 and $461 for the six months ended June 30, 2023 and 2022, respectively.

General and administrative expenses consist primarily of wages and benefits associated with management and administrative support departments, business insurance costs, professional fees, office facility related expenses, and other general support costs.

(o) Supplier Finance Programs

During 2022, we entered into an agreement with a third-party financial institution and an agreement with an insurance agency which allows us to obtain extended payment terms for our insurance policies. The insurance policies can be canceled by the Company at any time with 10 days’ notice. The financial institution may cancel this agreement after providing 10 days’ notice if the Company does not pay any installment payment according to the terms of the agreement. We do not provide any forms of guarantees under these agreements. Payments of our obligations are included in cash flows from operating activities in the Condensed Consolidated Statements of Cash Flows. Outstanding confirmed amounts are $73 and $218 as of June 30, 2023 and December 31, 2022, respectively, which will be recognized on the Condensed Consolidated Financial Statements as payments are due.

Note 2. Liquidity

Primarily due to a decline in net sales, disruption of our international sales to China, and increases in costs associated with the manufacture and distribution of our products, the Company has sustained significant losses from operations in several reporting periods since 2019. Absent any other action, the Company previously believed it would require additional liquidity to continue its operations over the next 12 months.

Due to the sales of our BIZ® and Alpha® brands as disclosed in Note 3 to the Condensed Consolidated Financial Statements, which generated $3,700 of cash in July and August 2023, we have fully repaid all long-term debt as of July 2023. While, absent any other actions, our operating activities are still expected to result in negative cash flows, we now expect to have enough liquidity to finance operations for the next 12 months. Management has recently implemented actions to reduce the Company’s operating expenses through asset sales, consolidation of vendors, and personnel reductions. To further reduce operating losses, the Company is considering additional various strategic actions including asset sales, obtaining additional debt or equity financing (potentially in conjunction with acquisitions), workforce reduction, deferring or eliminating certain capital expenditures, and further reduction of other operating expenses to ensure alignment with customer demand in order to address long-term liquidity needs and pursue its business plan. The Company expects that these strategic actions will further reduce expenses and provide required liquidity for ongoing operations.

Note 3. Divestitures

Alpha® Skin Care

Closed in July 2023 and effective June 30, 2023, we entered into a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Alpha® Skin Care brand. The transactions contemplated by the Alpha® Purchase Agreement were subject to customary conditions and closing deliveries by both the Company and the buyer and was consummated on July 31, 2023. The Company received payments of $2,500 and $200 in July 2023 and August 2023, respectively, representing total consideration for the sale of the Alpha Skin Care brand in the amount of $2,700 and an estimated gain on the sale of assets of $1,585 that will be recognized in the third quarter of 2023. The assets of Alpha® are classified as assets held for sale as of June 30, 2023 and December 31, 2022, and their operations have been classified as income from discontinued operations for all periods presented.

10


 

BIZ®

Closed in July 2023 and effective June 30, 2023, we entered into a purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the BIZ® brand. The transactions contemplated by the BIZ® Purchase Agreement were consummated on July 7, 2023. The total consideration paid to us was $1,000, plus an amount equal to the value of the BIZ® inventory, valued at $946 as of the effective date of the agreement, subject to post-close adjustment. The estimated gain on the sale of assets is $787 and will be recognized in the third quarter of 2023. The assets of BIZ® are classified as assets held for sale as of June 30, 2023 and December 31, 2022, and their operations have been classified as income from discontinued operations for all periods presented.

Scott's Liquid Gold Wood® Care and Scott's Liquid Gold® Floor Restore

On January 23, 2023, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell all of our right, title and interest in and to certain assets of the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore product lines. The total consideration paid to us was $800, plus an amount equal to the value of the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore inventory of $1,136, subject to post-close adjustment. Additionally, the buyer will pay a royalty equal to 2% of gross sales for two years after the closing date (the "Scott's Liquid Gold® Royalty"). The Scott's Liquid Gold® Royalty resulted in recognition of a gain upon the sale of assets. Because the Scott's Liquid Gold® Royalty is variable consideration and is contingent on the outcome of future events that are largely outside of the Company’s control, the variable consideration from the Scott's Liquid Gold® Royalty has been fully constrained and no amount is included in the results from discontinued operations. Consideration for the Scott's Liquid Gold® Royalty is to be recognized as received from the buyer. The constraint on the variable consideration will be reassessed at each subsequent reporting period. We have reflected the operations of the Scott's Liquid Gold® product lines as discontinued operations.

Prell®

On December 15, 2022, we entered into an asset purchase agreement with a buyer, pursuant to which we agreed to sell to all of our right, title and interest in and to certain assets of the Prell® product line. The total consideration paid to us was $150, plus an amount equal to the value of the Prell® inventory of $330, subject to post-close adjustment. Additionally, the buyer will pay a royalty equal to 3% of collections on net sales for four years after the closing date (the “Prell® Royalty”). The Prell® Royalty resulted in recognition of a gain upon the sale of assets. For the six months ended June 30, 2023 there were no changes in the assessment of the Prell® Royalty, which will continue to be recognized as received from the buyer. The constraint on the variable consideration will be reassessed at each subsequent reporting period. We have reflected the operations of the Prell® product line as discontinued operations.

Our Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations report discontinued operations separate from continuing operations. Our Condensed Consolidated Statements of Equity and Statements of Cash Flows combine the results of continuing and discontinued operations. A summary of financial information related to our discontinued operations is as follows:

Reconciliation of the Line Items Constituting Pretax Loss from Discontinued Operations to the After-Tax Loss from Discontinued Operations in the Condensed Consolidated Statements of Operations for the three and six months ended June 30:

 

 

Three Months Ended June 30, 2023

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

514

 

 

$

1,011

 

 

$

-

 

 

$

-

 

 

$

1,525

 

Cost of sales

 

209

 

 

 

732

 

 

 

-

 

 

 

-

 

 

 

941

 

Gross profit

 

305

 

 

 

279

 

 

 

-

 

 

 

-

 

 

 

584

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

80

 

 

 

204

 

 

 

-

 

 

 

-

 

 

 

284

 

General and administrative

 

10

 

 

 

12

 

 

 

-

 

 

 

-

 

 

 

22

 

Intangible asset amortization

 

-

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

6

 

Operating income from discontinued operations

 

215

 

 

 

57

 

 

 

-

 

 

 

-

 

 

 

272

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

(44

)

 

 

-

 

 

 

-

 

 

 

(44

)

Income from discontinued operations

$

215

 

 

$

13

 

 

$

-

 

 

$

-

 

 

$

228

 

 

11


 

 

 

Three Months Ended June 30, 2022

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

1,057

 

 

$

1,363

 

 

$

753

 

 

$

1,090

 

 

$

4,263

 

Cost of sales

 

401

 

 

 

952

 

 

 

470

 

 

 

548

 

 

 

2,371

 

Gross profit

 

656

 

 

 

411

 

 

 

283

 

 

 

542

 

 

 

1,892

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

169

 

 

 

328

 

 

 

202

 

 

 

200

 

 

 

899

 

Intangible asset amortization

 

-

 

 

 

6

 

 

 

12

 

 

 

-

 

 

 

18

 

Operating income from discontinued operations

 

487

 

 

 

77

 

 

 

69

 

 

 

342

 

 

 

975

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

(44

)

 

 

(14

)

 

 

(54

)

 

 

(112

)

Income from discontinued operations

$

487

 

 

$

33

 

 

$

55

 

 

$

288

 

 

$

863

 

 

 

Six Months Ended June 30, 2023

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

879

 

 

$

2,164

 

 

$

-

 

 

$

187

 

 

$

3,230

 

Cost of sales

 

278

 

 

 

1,510

 

 

 

-

 

 

 

95

 

 

 

1,883

 

Gross profit

 

601

 

 

 

654

 

 

 

-

 

 

 

92

 

 

 

1,347

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

141

 

 

 

437

 

 

 

-

 

 

 

28

 

 

 

606

 

General and administrative

 

10

 

 

 

12

 

 

 

-

 

 

 

22

 

 

 

44

 

Intangible asset amortization

 

-

 

 

 

12

 

 

 

-

 

 

 

-

 

 

 

12

 

Operating income from discontinued operations

 

450

 

 

 

193

 

 

 

-

 

 

 

42

 

 

 

685

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

(88

)

 

 

-

 

 

 

(18

)

 

 

(106

)

Gain on sale of discontinued operations

 

-

 

 

 

-

 

 

 

-

 

 

 

787

 

 

 

787

 

Income from discontinued operations

$

450

 

 

$

105

 

 

$

-

 

 

$

811

 

 

$

1,366

 

 

 

Six Months Ended June 30, 2022

 

 

Alpha®

 

 

BIZ®

 

 

Prell®

 

 

Scott's Liquid Gold®

 

 

Total

 

Net sales

$

1,917

 

 

$

2,423

 

 

$

1,591

 

 

$

2,313

 

 

$

8,244

 

Cost of sales

 

684

 

 

 

1,707

 

 

 

966

 

 

 

1,022

 

 

 

4,379

 

Gross profit

 

1,233

 

 

 

716

 

 

 

625

 

 

 

1,291

 

 

 

3,865

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

280

 

 

 

677

 

 

 

492

 

 

 

489

 

 

 

1,938

 

Intangible asset amortization

 

-

 

 

 

12

 

 

 

24

 

 

 

-

 

 

 

36

 

Operating income from discontinued operations

 

953

 

 

 

27

 

 

 

109

 

 

 

802

 

 

 

1,891

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

 

 

(88

)

 

 

(27

)

 

 

(108

)

 

 

(223

)

Income (loss) from discontinued operations

$

953

 

 

$

(61

)

 

$

82

 

 

$

694

 

 

$

1,668

 

There were no capital expenditures or significant operating and investing noncash items related to discontinued operations during the six months ended June 30, 2023 and 2022, respectively.

12


 

Reconciliation of Major Classes of Assets of the Discontinued Operations to Amounts Presented Separately in the Consolidated Balance Sheets as of:
 

 

June 30, 2023

 

 

December 31, 2022

 

Assets

 

 

 

 

 

Inventories

$

-

 

 

$

1,235

 

All assets in the above table are related to the discontinued operations of Scott's Liquid Gold®. There were no assets of discontinued operations related to Prell®, BIZ®, and Alpha® as of June 30, 2023 and December 31, 2022, respectively.

Assets Held for Sale

The following tables set forth the assets held for sale as of:

 

 

June 30, 2023

 

 

BIZ®

 

 

Alpha®

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Inventories

$

946

 

 

$

1,115

 

 

$

2,061

 

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

219

 

 

 

-

 

 

 

219

 

Assets held for sale

$

1,165

 

 

$

1,115

 

 

$

2,280

 

 

 

December 31, 2022

 

 

BIZ®

 

 

Alpha®

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Inventories

$

1,092

 

 

$

1,268

 

 

$

2,360

 

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

231

 

 

 

-

 

 

 

231

 

Assets held for sale

$

1,323

 

 

$

1,268

 

 

$

2,591

 

We measured the assets held for sale at the lower of their carrying value or fair value less costs to sell. We did not record any impairment charges in the second quarter of 2023.

Note 4. Stock-Based Compensation

On May 11, 2023, we granted 200 shares of restricted stock to two directors all of which vested on the grant date with a fair value of $40.

On March 2, 2022, we granted 15 shares of restricted stock to one executive all of which vested on the grant date with a fair value of $18.

On January 18, 2022, we granted 25 RSUs to an employee (the “2022 Individual Employee Grant”) with a grant date fair value of $10. The 2022 Individual Employee Grant vested one-third on the initial grant date, and the remaining two-thirds will vest on each anniversary of the grant date.

Compensation cost related to stock options totaled $0 and $10 in the six months ended June 30, 2023 and 2022, respectively. The stock options were fully vested in the second quarter of 2022. There was no tax benefit from recording the non-cash expense as it relates to the options granted to employees, as these were qualified stock options which are not normally tax deductible.

Compensation cost related to RSUs totaled $57 and $76 for the six months ended June 30, 2023 and 2022, respectively. Approximately $54 of total unrecognized compensation costs related to non-vested RSUs is expected to be recognized over the next three years.

13


 

Note 5. Earnings per Share

Per share data is determined by using the weighted average number of common shares outstanding. Common equivalent shares are considered only for diluted earnings per share, unless considered anti-dilutive. Common equivalent shares, determined using the treasury stock method, result from stock options with exercise prices that are below the average market price of the common stock.

Basic earnings per share include no dilution and are computed by dividing income available to common shareholders by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential of securities that could share in our earnings.

A reconciliation of the weighted average number of common shares outstanding (in thousands) is as follows. The dilutive effect of stock options and RSUs is excluded for periods in which the impact is anti-dilutive and when the Company has a net loss because the impact is also anti-dilutive.

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Common shares outstanding, beginning of the period

 

12,797

 

 

 

12,749

 

 

 

12,797

 

 

 

12,727

 

Weighted average common shares issued

 

111

 

 

 

-

 

 

 

56

 

 

 

18

 

Weighted average number of common shares outstanding

 

12,908

 

 

 

12,749

 

 

 

12,853

 

 

 

12,745

 

Dilutive effect of common share equivalents

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Diluted weighted average number of common shares outstanding

 

12,908

 

 

 

12,749

 

 

 

12,853

 

 

 

12,745

 

 

Common stock equivalents (in thousands) that have been excluded from the calculation of earnings per share because they would have been anti-dilutive are as follows:

 

 

Three Months and Six Months Ended June 30,

 

 

2023

 

 

2022

 

Stock options

 

60

 

 

 

213

 

Restricted stock units

 

31

 

 

 

104

 

 

Note 6. Segment Information

We operate in two different segments: household products and health and beauty care products. We have chosen to organize our business around these segments based on differences in the products sold. Accounting policies for our segments are the same as those described in Note 1. We evaluate segment performance based on segment income or loss from operations.

The following provides information on our segments for the three and six months ended June 30:

 

 

Three Months Ended June 30, 2023

 

 

Household Products

 

 

Health and Beauty Care Products

 

 

Total

 

Net sales

$

847

 

 

$

691

 

 

$

1,538

 

Loss from operations

 

(527

)

 

 

(142

)

 

 

(669

)

Capital and intangible asset expenditures

 

-

 

 

 

-

 

 

 

-

 

Depreciation and amortization

 

56

 

 

 

6

 

 

 

62

 

 

 

Three Months Ended June 30, 2022

 

 

Household Products

 

 

Health and Beauty Care Products

 

 

Total

 

Net sales

$

692

 

 

$

428

 

 

$

1,120

 

Loss from operations

 

(4,567

)

 

 

(559

)

 

 

(5,126

)

Capital and intangible asset expenditures

 

43

 

 

 

-

 

 

 

43

 

Depreciation and amortization

 

148

 

 

 

27

 

 

 

175

 

 

14


 

 

Six Months Ended June 30, 2023

 

 

Household Products

 

 

Health and Beauty Care Products

 

 

Total

 

Net sales

$

1,669

 

 

$

1,599

 

 

$

3,268

 

Loss from operations

 

(1,049

)

 

 

(286

)

 

 

(1,335

)

Capital and intangible asset expenditures

 

-

 

 

 

-

 

 

 

-

 

Depreciation and amortization

 

213

 

 

 

11

 

 

 

224

 

 

 

Six Months Ended June 30, 2022

 

 

Household Products

 

 

Health and Beauty Care Products

 

 

Total

 

Net sales

$

1,619

 

 

$

1,309

 

 

$

2,928

 

Loss from operations

 

(5,313

)

 

 

(1,030

)

 

 

(6,343

)

Capital and intangible asset expenditures

 

142

 

 

 

-

 

 

 

142

 

Depreciation and amortization

 

287

 

 

 

52

 

 

 

339

 

 

Note 7. Intangible Assets

Intangible assets, which are comprised of our capitalized costs of software obtained for internal-use or are related to our acquisition of our Denorex® brand, consisted of the following:

 

As of June 30, 2023

 

 

As of December 31, 2022

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Value

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Value

 

Intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade names

$

159

 

 

$

100

 

 

$

59

 

 

$

159

 

 

$

97

 

 

$

62

 

Formulas and batching processes

 

333

 

 

 

290

 

 

 

43

 

 

 

333

 

 

 

282

 

 

 

51

 

Internal-use software

 

898

 

 

 

195

 

 

 

703

 

 

 

898

 

 

 

105

 

 

 

793

 

Non-compete agreement

 

30

 

 

 

30

 

 

 

-

 

 

 

30

 

 

 

30

 

 

 

-

 

 

$

1,420

 

 

$

615

 

 

$

805

 

 

$

1,420

 

 

$

514

 

 

$

906

 

Amortization expense for the three months ended June 30, 2023 and 2022 was $51 and $103, respectively. Amortization expense for the six months ended June 30, 2023 and 2022 was $101 and $226, respectively.

Estimated amortization expense for 2023 and subsequent years is as follows:
 

Remainder of 2023

$

100

 

2024

 

201

 

2025

 

201

 

2026

 

192

 

2027

 

81

 

Thereafter

 

30

 

Total

$

805

 

 

Note 8. Long-Term Debt

UMB Loan Agreement

On July 1, 2020, we entered into a Loan and Security Agreement (as amended, the “UMB Loan Agreement”) with UMB Bank, N.A. Under the UMB Loan Agreement we obtained a $3,000 term loan, with equal monthly payments fully amortized over three years which was repaid in full in the second quarter of 2022, and a revolving credit facility, with a maximum commitment of $4,000 bearing interest at the one-month term SOFR rate + 6.83% with a floor of 7.75%.

The UMB Loan Agreement was terminated on February 27, 2023 and the revolving credit facility was paid in full on February 28, 2023. The loans were secured by all of the assets of the Company and its subsidiaries. Unamortized loan costs were $0 and $100 as of June 30, 2023 and December 31, 2022, respectively. Amortization of loan costs for the six months ended June 30, 2023 was $100, including $83 that were expensed as a result of the termination of the UMB Loan Agreement. Amortization of loan costs for the six months ended June 30, 2022 was $99.

15


 

La Plata Loan Agreement

On November 9, 2021, we entered into a loan and security agreement (as amended, the “La Plata Loan Agreement”) with La Plata Capital, LLC (“La Plata”). Under the La Plata Loan Agreement, we obtained a $2,000 term loan that bears interest at 14% and a $250 term loan that bears interest at 15%. We repaid $1,000 of principal against the La Plata Loan Agreement during the first quarter of 2022.

Unamortized loan costs were $9 and $20 as of June 30, 2023 and December 31, 2022, respectively. Amortization of loan costs for the six months ended June 30, 2023 and 2022 were $11, respectively.

On July 7, 2023, the La Plata term loans were paid in full and the La Plata Loan Agreement was terminated.
 

Note 9. Leases

We have entered into a lease for our corporate headquarters with a remaining lease term of 7 years. This lease includes both lease and nonlease components, which are accounted for as a single lease component as we have elected the practical expedient to combine these components for all leases. As this lease does not provide an implicit rate, we calculated the right-of-use assets and lease liabilities using our secured incremental borrowing rate at the lease commencement date. We currently do not have any finance leases outstanding.

Information related to leases was as follows:

 

 

Three Months Ended June 30, 2023

 

Six Months Ended June 30, 2023

 

Operating lease information:

 

 

 

 

Operating lease cost

$

101

 

$

203

 

Operating cash flows from operating leases

 

101

 

 

203

 

Net assets obtained in exchange for new operating lease liabilities

 

-

 

 

-

 

 

 

 

 

 

Weighted average remaining lease term in years

 

7.42

 

 

7.42

 

Weighted average discount rate

 

5.1

%

 

5.1

%

 

 

Three Months Ended June 30, 2022

 

Six Months Ended June 30, 2022

 

Operating lease information:

 

 

 

 

Operating lease cost

$

100

 

$

200

 

Operating cash flows from operating leases

 

100

 

 

200

 

Net assets obtained in exchange for new operating lease liabilities

 

-

 

 

-

 

 

 

 

 

 

Weighted average remaining lease term in years

 

8.42

 

 

8.42

 

Weighted average discount rate

 

5.1

%

 

5.1

%

Future minimum annual lease payments are as follows:

 

Remainder of 2023

$

203

 

2024

 

413

 

2025

 

420

 

2026

 

427

 

2027

 

434

 

Thereafter

 

1,305

 

Total minimum lease payments

$

3,202

 

Less imputed interest

 

(553

)

 

 

 

Total operating lease liability

$

2,649

 

 

 

 

16


 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Company’s Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022. This Item 2 contains forward-looking statements. The matters discussed in these forward-looking statements are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from those made, projected, or implied in the forward-looking statements. Please refer to "Item 1A. Risk Factors" in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2022 for a discussion of the uncertainties, risks and assumptions associated with these statements.

Executive Overview

Our Business

Scott’s Liquid Gold-Inc. exists to positively impact consumers’ lives in the markets we serve while creating shareholder value. We develop, market, and sell high-quality, high-value household and health and beauty care products nationally and internationally to mass merchandisers, drugstores, supermarkets, hardware stores, e-commerce retailers, other retail outlets, and to wholesale distributors.

Primarily due to a decline in net sales, disruption of our international sales to China, and increases in costs associated with the manufacture and distribution of our products, the Company has experienced negative cash flows from operations for several reporting periods. In efforts to improve our financial position and liquidity, the Company has pursued asset sales of certain brands where management has determined that the brand(s) are not aligned with our long-term goals for growth and profitability. The Company will continue to consider a wide range of options, including one or more of the following: the sale of additional brands; a sale, merger, or other strategic transaction involving the entire company; acquisitions of other brands or companies; issuance of additional debt or equity; and continuing to operate as a public, independent company.

Divestitures

Closed in July 2023 and effective June 30, 2023, we sold the Alpha® Skin Care product line to a company that markets and distributes skin care products. Closed in July 2023 and effective June 30, 2023, we sold the BIZ® product line to a company that markets and distributes laundry products. The assets of Alpha® and BIZ® are classified as assets held for sale as of June 30, 2023 and December 31, 2022, and their operations have been classified as income from discontinued operations for all periods presented. On January 23, 2023, we sold the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore product lines to a company that markets and distributes wood care products. On December 15, 2022, we sold the Prell® brand to a company that markets and distributes natural hair and skincare products. We have reflected the operations of Scott's Liquid Gold® and Prell® as discontinued operations for all periods presented.

See Note 3 - “Discontinued Operations and Assets Held for Sale” in the Notes to Condensed Consolidated Financial Statements for further information on the sale of these brands.

In conjunction with the sale of the Scott’s Liquid Gold® brand, as discussed below, the Company may continue to use names “Scott’s Liquid Gold” and “SLG” for up to one year following the closing date of the agreement on January 23, 2023. Following this transitional name period, the Company will only be able to use the aforementioned names in connection with retaining records and other historical or archived documents and any use required by or permitted as a fair use or otherwise under applicable law.

17


 

Results of Operations

Three months ended June 30, 2023 compared to three months ended June 30, 2022

 

 

Three Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

1,538

 

 

$

1,120

 

 

$

418

 

 

 

37.3

%

Cost of sales

 

824

 

 

 

737

 

 

 

87

 

 

 

11.8

%

Gross profit

 

714

 

 

 

383

 

 

 

331

 

 

 

86.4

%

Gross margin

 

46.4

%

 

 

34.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

120

 

 

 

174

 

 

 

(54

)

 

 

(31.0

%)

Selling

 

574

 

 

 

867

 

 

 

(293

)

 

 

(33.8

%)

General and administrative

 

638

 

 

 

776

 

 

 

(138

)

 

 

(17.8

%)

Intangible asset amortization

 

51

 

 

 

103

 

 

 

(52

)

 

 

(50.5

%)

Impairment of goodwill and intangible assets

 

-

 

 

 

3,589

 

 

 

(3,589

)

 

 

(100.0

%)

Total operating expenses

 

1,383

 

 

 

5,509

 

 

 

(4,126

)

 

 

(74.9

%)

Loss from operations

 

(669

)

 

 

(5,126

)

 

 

4,457

 

 

 

86.9

%

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(6

)

 

 

(18

)

 

 

12

 

 

 

66.7

%

Loss before income taxes and discontinued operations

 

(675

)

 

 

(5,144

)

 

 

4,469

 

 

 

86.9

%

Income tax expense

 

(6

)

 

 

(52

)

 

 

46

 

 

 

88.5

%

Loss from continuing operations

 

(681

)

 

 

(5,196

)

 

 

4,515

 

 

 

86.9

%

Income from discontinued operations

 

228

 

 

 

863

 

 

 

(635

)

 

 

(73.6

%)

Net loss

$

(453

)

 

$

(4,333

)

 

$

3,880

 

 

 

89.5

%

Our operating results were primarily impacted by the following:

Increases in net sales, cost of sales, and gross profit are due to increased distribution of our products sold at existing and certain new customers.
Decrease in selling expenses is primarily due to lower logistics and warehousing costs from a consolidation of our third-party logistics partners, and a reduction in personnel costs related to asset divestitures.
Decreased general and administrative costs primarily due to a reduction in legal and professional fees, lower bank charges from the termination of our UMB Loan Agreement, and reduced personnel costs.
Decreased intangible asset amortization from reduced carrying amounts related to impairments recognized in 2022.
Results from discontinued operations, which are disclosed in Note 3 to the Condensed Consolidated Financial Statements.

18


 

Segment Results

Household products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume, and percentage changes for household products between periods:

 

 

Three Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

847

 

 

$

692

 

 

$

155

 

 

 

22.4

%

Gross profit

$

392

 

 

$

186

 

 

$

206

 

 

 

110.8

%

Gross margin

 

46.3

%

 

 

26.9

%

 

 

 

 

 

 

Loss from operations

$

(527

)

 

$

(4,567

)

 

$

4,040

 

 

 

88.5

%

Net sales and gross profit increased due to additional sales of Kids N Pets® and Messy Pet® products to existing customers.
Loss from operations improved primarily due to decreased selling expenses from the consolidation of our third-party logistics partners. Our loss from operations in the second quarter of 2022 was impacted by the impairment of goodwill and intangible assets associated with our All-Purpose reporting unit.

Health and beauty care products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume and percentage changes for health and beauty care products between periods:

 

 

Three Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

691

 

 

$

428

 

 

$

263

 

 

 

61.4

%

Gross profit

$

322

 

 

$

197

 

 

$

125

 

 

 

63.6

%

Gross margin

 

46.7

%

 

 

46.0

%

 

 

 

 

 

 

Loss from operations

$

(142

)

 

$

(559

)

 

$

417

 

 

 

74.6

%

Net sales and gross profits increased due to additional sales of Denorex® to existing customers as well as sales growth to certain new customers.
Income from operations resulted from decreased selling expenses from the consolidation of our third-party logistics partners as well as a reduction in personnel costs.

19


 

Six months ended June 30, 2023 compared to six months ended June 30, 2022
 

 

Six Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

3,268

 

 

$

2,928

 

 

$

340

 

 

 

11.6

%

Cost of sales

 

1,826

 

 

 

1,599

 

 

 

227

 

 

 

14.2

%

Gross profit

 

1,442

 

 

 

1,329

 

 

 

113

 

 

 

8.5

%

Gross margin

 

44.1

%

 

 

45.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

275

 

 

 

326

 

 

 

(51

)

 

 

(15.6

%)

Selling

 

1,146

 

 

 

1,970

 

 

 

(824

)

 

 

(41.8

%)

General and administrative

 

1,255

 

 

 

1,561

 

 

 

(306

)

 

 

(19.6

%)

Intangible asset amortization

 

101

 

 

 

226

 

 

 

(125

)

 

 

(55.3

%)

Impairment of goodwill and intangible assets

 

-

 

 

 

3,589

 

 

 

(3,589

)

 

 

(100.0

%)

Total operating expenses

 

2,777

 

 

 

7,672

 

 

 

(4,895

)

 

 

(63.8

%)

Loss from operations

 

(1,335

)

 

 

(6,343

)

 

 

5,008

 

 

 

79.0

%

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(113

)

 

 

(57

)

 

 

(56

)

 

 

(98.2

%)

Loss before income taxes and discontinued operations

 

(1,448

)

 

 

(6,400

)

 

 

4,952

 

 

 

77.4

%

Income tax expense

 

(2

)

 

 

(52

)

 

 

50

 

 

 

96.2

%

Loss from continuing operations

 

(1,450

)

 

 

(6,452

)

 

 

5,002

 

 

 

77.5

%

Income from discontinued operations

 

1,366

 

 

 

1,668

 

 

 

(302

)

 

 

(18.1

%)

Net loss

$

(84

)

 

$

(4,784

)

 

$

4,700

 

 

 

98.2

%

Our operating results were primarily impacted by the following:

Increases in net sales, cost of sales, and gross profit are due to increased distribution of our products sold at existing and certain new customers.
Decrease in selling expenses is primarily due to lower logistics and warehousing costs from a consolidation of our third-party logistics partners, and a reduction in personnel costs related to asset divestitures.
Decreased general and administrative costs primarily due to a reduction in legal and professional fees, lower bank charges from the termination of our UMB Loan Agreement, and reduced personnel costs.
Decreased intangible asset amortization from reduced carrying amounts related to impairments recognized in 2022.
Results from discontinued operations, which are disclosed in Note 3 to the Condensed Consolidated Financial Statements.

20


 

Segment Results

Household products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume, and percentage changes for household products between periods:
 

 

Six Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

1,669

 

 

$

1,619

 

 

$

50

 

 

 

3.1

%

Gross profit

$

728

 

 

$

624

 

 

$

104

 

 

 

16.7

%

Gross margin

 

43.6

%

 

 

38.5

%

 

 

 

 

 

 

Loss from operations

$

(1,049

)

 

$

(5,313

)

 

$

4,264

 

 

 

80.3

%

Net sales and gross profit increased due to additional sales of Kids N Pets® and Messy Pet® products to existing customers. Gross margins improved due to impairments of inventories that occurred during the second quarter of 2022.
Loss from operations improved primarily due to decreased selling expenses from the consolidation of our third-party logistics partners. Our loss from operations in the second quarter of 2022 was impacted by the impairment of goodwill and intangible assets associated with our All-Purpose reporting unit.

Health and beauty care products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume and percentage changes for health and beauty care products between periods:
 

 

Six Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Net sales

$

1,599

 

 

$

1,309

 

 

 

290

 

 

 

22.1

%

Gross profit

$

714

 

 

$

705

 

 

$

9

 

 

 

1.2

%

Gross margin

 

44.6

%

 

 

53.9

%

 

 

 

 

 

 

Loss from operations

$

(286

)

 

$

(1,030

)

 

$

744

 

 

 

72.2

%

Net sales increased due to additional sales of Denorex® to existing customers as well as sales growth to certain new customers. Gross margin decreased due to rising costs of products, inventory impairments, and the sales mix of products sold to certain customers.
Loss from operations resulted from decreased selling expenses from the consolidation of our third-party logistics partners as well as a reduction in personnel costs.

Liquidity and Capital Resources

Overview

Our primary sources of funds include cash expected to be generated from operations and sale of brands. Our principal uses of cash are to fund planned operating expenditures. Working capital movements are influenced by the sourcing of materials related to the production of products.

Financing Agreements

Please see Note 8 to our Condensed Consolidated Financial Statements for information on our La Plata Loan Agreement, which was terminated in July 2023, and our UMB Loan Agreement, which was terminated in February 2023.

Liquidity and Changes in Cash Flows

At June 30, 2023, we had approximately $608 in cash on hand, an increase of $559 from December 31, 2022.

The following is a summary of cash provided by or (used in) each of the indicated types of activities:

21


 

 

 

Six Months Ended June 30, (in thousands)

 

 

 

 

 

 

 

 

Increase / (Decrease)

 

 

2023

 

 

2022

 

 

$

 

 

%

 

Operating activities

$

907

 

 

$

466

 

 

$

441

 

 

 

94.6

%

Investing activities

 

1,936

 

 

 

(142

)

 

 

2,078

 

 

 

1,463.4

%

Financing activities

 

(2,284

)

 

 

(1,278

)

 

 

(1,006

)

 

 

(78.7

%)

Net cash provided by operating activities was primarily related to conversion of working capital from accounts receivable and inventories.
Net cash provided by investing activities was due to the sale of our Scott's Liquid Gold® brand.
Net cash used in financing activities was from repayments and termination of our UMB Loan Agreement and offset by proceeds from our La Plata Loan Agreement.

The cash received from the sales of our BIZ® and Alpha® Skin Care brands in July and August 2023 was $3,700 and was partially used to pay off and terminate our La Plata Loan Agreement. While we believe that our current cash reserves represent sufficient cash flows to fund our operations, our liquidity has been affected by inflationary pressures at our customers which have caused sales decreases and higher costs on materials, logistics, and other purchases. We expect that our current cash reserves will be sufficient to meet operational cash needs during the next twelve months, but further economic impacts to our sales to customers or supply chain disruptions in the short-term could impact our liquidity.
 

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of June 30, 2023, we conducted an evaluation, under the supervision and with the participation of our President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on that evaluation, our President and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2023 due to a material weakness in our internal controls resulting from our finance department not being able to process and account for complex, non-routine transactions in accordance with GAAP. Management concluded that we lack a sufficient number of trained professionals with technical accounting expertise to process and account for complex and non-routine transactions.

Remediation Plan

We are committed to maintaining a strong internal control environment and we are developing a remediation plan designed to help ensure that this material weakness is remediated as soon as possible, by establishing internal control(s) to identify complex, non-routine accounting transactions and engaging the assistance of accounting expert(s) as needed to assist in the accounting and reporting of these transactions.

The material weakness will not be considered remediated until a sustained period of time has passed to allow management to test the design and operational effectiveness of the corrective actions. Until the material weakness is remediated, we plan to continue to perform additional analyses and other procedures to ensure that our Condensed Consolidated Financial Statements are prepared in accordance with GAAP.

Notwithstanding such material weakness in internal control over financial reporting, our President and Chief Financial Officer have concluded that the Condensed Consolidated Financial Statements in Part I, Item 1 of this report, present fairly, in all material respects, our financial position, results of operations, and cash flows for the periods presented in conformity with GAAP.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the three months ended June 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

22


 

PART II

 

ITEM 1A. RISK FACTORS

We have identified a material weakness in our internal control over financial reporting.

We are a public reporting company subject to the rules and regulations established from time to time by the SEC. As a public company we are required to document and test our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act so that our management can certify as to the effectiveness of our internal control over financial reporting.

As disclosed in Part I, Item 4, “Disclosure Controls and Procedures,” we have identified a material weakness in our controls related to our finance department lacking a sufficient number of trained professionals with technical accounting expertise to process and account for complex, non-routine transactions in accordance with GAAP as of June 30, 2023.

This material weakness did not result in any restatements to our Condensed Consolidated Financial Statements. Our management is committed to remediating this material weakness and is in the process of developing a remediation plan to address the material weakness.

In addition to the other information set forth in this Report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q, which could materially affect our business, financial condition, or future results.

 

ITEM 6. EXHIBITS

Exhibit Number

Document

10.1

 

Restricted Stock Award Agreement, dated May 15, 2023, between Scott's Liquid Gold-Inc. and Daniel Roller

10.2

 

Asset Purchase Agreement, by and among the Company, SLG Chemicals, Inc. and Commercial Brands LLC, dated June 30, 2023

10.3

 

Asset Purchase Agreement, by and among the Company, Neoteric Cosmetics, Inc. and Alpha Skin LLC dated June 30, 2023

31.1

Rule 13a-14(a) Certification of the President.

31.2

Rule 13a-14(a) Certification of the Chief Financial Officer.

32.1*

Section 1350 Certification.

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

* Furnished, not filed.

 

23


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SCOTT’S LIQUID GOLD-INC.

 

By:

/s/ Tisha Pedrazzini

Tisha Pedrazzini, President

(Principal Executive Officer)

 

 

By:

/s/ David M. Arndt

David M. Arndt, Chief Financial Officer

(Principal Financial and Chief Accounting Officer)

Date: August 14, 2023

24